Table 1. Characteristics of patients included in the study group and the control group.

Characteristics	Study group (n=20)	Control group (n=20)
Age/years
Range	7–16	7–16
Median	11	11
Gender
Female	9	10
Male	11	10
Post-transplant status of disease
Complete remission	15	16
Partial remission	2	1
Chronic phase of disease	3	4
Dose of stem cells (×106 per kg of CD34*)	6.04	5.85